Main Corporate Website: http://us-stemcell.com/
Symbol: $USRM (Formerly named Bioheart and former trading symbol $BHRT) All SEC filings for $USRM can be found here on the SEC EDGAR database: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001388319&owner=exclude&count=40&hidefilings=0 OTC Markets Site: Pink (Status: Pink No information) https://www.otcmarkets.com/stock/USRM/overview ___________________________________________________________________________________________________________________________________________________________________________ Pink No Information Delinquent SEC Reporting Warning! This company may not be making material information publicly available
Current Corporate Address in a shared-space "virtual office" (after apparently abandoning their former long-time Sunrise, FL corporate headquarters and lab facilities per SEC filings): U.S. Stem Cell, Inc. 1560 Sawgrass Corporate Pkwy 4th Floor Sunrise FL, 33323 Phone: 954-835-1500 Former address until 9/30/2019 was: 13794 NW 4th Street, Suite 212, Sunrise, Florida 33325 Key National News and Press Events and SEC Filed Actions For U.S. Stem Cell Inc, Formerly Known as Bioheart: 1) A 1-for-1000 reverse stock split of their common shares, along with the change of their corporate name to U.S. Stem Cell from "Bioheart" was filed with the SEC and affected on Nov 18, 2015: https://www.sec.gov/Archives/edgar/data/1388319/000118518515002742/usstemcell8k110315.htm http://us-stemcell.com/u-s-stem-cell-inc-fka-bioheart-inc-receives-finra-approval-for-reverse-split-and-name-change/ 2) At least three women went blind after receiving stem cell injections into their eyes, prepared and administered and using products made by U.S. Stem Cell. This led to news and events and lawsuits that made world-wide news in essentially every major news source and newspaper and also the New England Journal Of Medicine among numerous other medical journals. The blinding of the women helped lead to a major FDA investigation of the company (Bioheart) now renamed U.S. Stem Cell, and eventually a U.S. Department of Justice and FDA lawsuit filed against U.S. Stem Cell Incorporated among other named defendants: https://ipscell.com/2017/12/new-lawsuit-against-u-s-stem-cell-alleges-blindness/ https://www.nytimes.com/2017/03/15/health/eyes-stem-cells-injections.html https://www.washingtonpost.com/national/health-science/this-clinics-experimental-stem-cell-treatment-blinded-patients-four-years-later-the-government-is-still-trying-to-shut-it-down/2019/04/03/432d6d04-ff2f-11e8-83c0-b06139e540e5_story.html 3) The FDA and U.S. Department Of Justice File Lawsuit Against U.S. Stem Cell (Formerly Bioheart) in landmark legal case: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/us-stem-cell-clinic-llc-524470-08242017 https://www.justice.gov/opa/pr/department-justice-files-complaints-against-florida-and-california-companies-stop-use https://www.fda.gov/news-events/press-announcements/federal-court-issues-decision-holding-us-stem-cell-clinics-and-owner-adulterated-and-misbranded-stem Press Releases: http://www.otcmarkets.com/stock/USRM/news